Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
2099.5000 -33.00 (-1.55%)
NSE Sep 15, 2025 15:31 PM
Volume: 546.8K
 

announcement
Conference/Earnings Calls Alerts
logo
Glenmark Pharmaceuticals Ltd.
18 Aug 2025
2099.50
-1.55%
Glenmark Pharmaceuticals Results Earnings Call for Q1FY26
Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
More from Glenmark Pharmaceuticals Ltd.
Recommended
IPO market buzz: Five new issues, eleven listings this week
| 15 Sep 2025, 04:32PM
Market closes lower, Tata Tech to buy Germany-based ES-Tec Group for €75 million
Trendlyne Marketwatch | 15 Sep 2025, 04:03PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
| 29 Jun 2020